SEC Form 4 · accession 0001213900-15-000220
MYOS RENS TECHNOLOGY INC. · MYOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert C. Ashton Jr.
Officer — Chief Medical Officer
Period of report
Jan 12, 2015
Accepted (ET)
Jan 12, 2015 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402479
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $12.50 | Jan 12, 2015 | A | 10,000 | A | — | Jan 12, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The Stock Option vests in four equal annual installments commencing on January 12, 2016.